InvestorsHub Logo

BTH

10/29/10 8:25 AM

#3009 RE: DonShimoda #3007

While some on this board insist the company should partner now and start global head to head, multi-arm trials



Who's insisting on that?

I would think Ariad would need to be approved in any indication for CML before they did something like that.

The only reason for a larger partner at this point is to start in other indications like solid-tumors.